Education
About Us
Working with TipRanks
Follow Us
Hims & Hers Health (HIMS)
NYSE:HIMS
HIMS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$16.05 - $72.98
Previous CloseN/A
Volume4.28M
Average Volume (3M)27.01M
Market Cap
$13.04B
Enterprise Value$12.70B
Total Cash (Recent Filing)$1.14B
Total Debt (Recent Filing)$1.04B
Price to Earnings (P/E)70.1
Beta2.61
Next Earnings
Nov 10, 2025EPS Estimate
0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.17
Shares Outstanding217,641,950
10 Day Avg. Volume31,792,823
30 Day Avg. Volume27,009,637
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.97
Enterprise Value/Revenue6.31
Enterprise Value/Gross Profit8.28
Enterprise Value/Ebitda82.06
Forecast
1Y Price Target
$49.40Price Target Upside-7.23% Downside
Rating ConsensusHold
Number of Analyst Covering12
Bulls Say, Bears Say
Bulls Say
New Product LaunchesIncrementally more confident that new product launches, particularly the upcoming standalone testing service, will re-accelerate core growth.
Sales PerformanceObserved sales strengthened in August driven by GLP-1s and point to online revenue in the range ahead of Street estimates.
Bears Say
Growth ConcernsApp downloads declined by 22% and web traffic was down 10% in August.
Regulatory ChallengesHIMS' marketing campaigns will be under intense scrutiny, which will likely increase customer acquisition costs.
Hims & Hers Health News
HIMS FAQ
What was Hims & Hers Health’s price range in the past 12 months?
Hims & Hers Health lowest stock price was $16.05 and its highest was $72.98 in the past 12 months.
What is Hims & Hers Health’s market cap?
Hims & Hers Health’s market cap is $13.04B.
When is Hims & Hers Health’s upcoming earnings report date?
Hims & Hers Health’s upcoming earnings report date is Nov 10, 2025 which is in 45 days.
How were Hims & Hers Health’s earnings last quarter?
Hims & Hers Health released its earnings results on Aug 04, 2025. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.151 by $0.019.
Is Hims & Hers Health overvalued?
According to Wall Street analysts Hims & Hers Health’s price is currently Overvalued.
Does Hims & Hers Health pay dividends?
Hims & Hers Health does not currently pay dividends.
What is Hims & Hers Health’s EPS estimate?
Hims & Hers Health’s EPS estimate is 0.1.
How many shares outstanding does Hims & Hers Health have?
Hims & Hers Health has 217,641,950 shares outstanding.
What happened to Hims & Hers Health’s price movement after its last earnings report?
Hims & Hers Health reported an EPS of $0.17 in its last earnings report, beating expectations of $0.151. Following the earnings report the stock price went down -12.36%.
Which hedge fund is a major shareholder of Hims & Hers Health?
Currently, no hedge funds are holding shares in HIMS
Hims & Hers Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$49.40 (-7.23% Downside)
$49.40 (-7.23% Downside)
Blogger Sentiment
Bullish
HIMS Sentiment 84%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Increased
By 101.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $37.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▲ 0.8%
Last 30 Days ▲ 0.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
208.33%
12-Months-Change
Fundamentals
Return on Equity
41.88%
Trailing 12-Months
Asset Growth
290.76%
Trailing 12-Months
Company Description
Hims & Hers Health
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
HIMS Company Deck
HIMS Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlights strong revenue growth, international expansion, and technological advancements, signaling a positive outlook for the company's future. However, challenges such as the decline in GLP-1 subscribers and increased costs present hurdles. The balance of positive growth metrics against operational challenges results in a mixed sentiment.View all HIMS earnings summariesHIMS Revenue Breakdown
96.60% Online
3.40% Wholesale
HIMS Stock 12 Month Forecast
Average Price Target
$49.40
▼(-7.23% Downside)
Technical Analysis
Ownership Overview
5.25% Insiders
19.80% Mutual Funds
25.57% Other Institutional Investors
29.98% Public Companies and Individual Investors